Activation of the ATF2/CREB-PGC-1α pathway by metformin leads to dopaminergic neuroprotection
Hojin Kang(Samsung (South Korea)), Joo‐Ho Shin(Chonnam National University), Chi‐Hu Park(Samsung (South Korea)), Ga Ram Jeong(Kyung Hee University), Sangwoo Ham(Samsung (South Korea)), Sun Ha Paek(Seoul National University), Jeong-Kon Seo(Ulsan National Institute of Science and Technology), Hye-In Kim(Samsung (South Korea)), Hyojung Kim(Samsung (South Korea)), Byoung Dae Lee(Kyung Hee University), Yunjong Lee(Sungkyunkwan University), Areum Jo(Sungkyunkwan University), Jeong‐Yun Choi(Sungkyunkwan University), Yun‐Song Lee(Daegu Gyeongbuk Institute of Science and Technology), Rin Khang(Samsung (South Korea)), Yun Il Lee(Daegu Gyeongbuk Institute of Science and Technology), Minkyung Jo(Samsung (South Korea))
Cited by 70
Related Papers
Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson’s disease
|Nature Medicine|2018|1.2k
PARIS (ZNF746) Repression of PGC-1α Contributes to Neurodegeneration in Parkinson's Disease
|Cell|2011|951
Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin's ubiquitination and protective function
|Proceedings of the National Academy of Sciences|2010|282
Iduna is a poly(ADP-ribose) (PAR)-dependent E3 ubiquitin ligase that regulates DNA damage
|Proceedings of the National Academy of Sciences|2011|263
Parkin loss leads to PARIS-dependent declines in mitochondrial mass and respiration
|Proceedings of the National Academy of Sciences|2015|259